Literature DB >> 18627268

Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions.

Rita B Effros1, Courtney V Fletcher, Kelly Gebo, Jeffrey B Halter, William R Hazzard, Frances McFarland Horne, Robin E Huebner, Edward N Janoff, Amy C Justice, Daniel Kuritzkes, Susan G Nayfield, Susan F Plaeger, Kenneth E Schmader, John R Ashworth, Christine Campanelli, Charles P Clayton, Beth Rada, Nancy F Woolard, Kevin P High.   

Abstract

Highly active antiretroviral treatment has resulted in dramatically increased life expectancy among patients with HIV infection who are now aging while receiving treatment and are at risk of developing chronic diseases associated with advanced age. Similarities between aging and the courses of human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome suggest that HIV infection compresses the aging process, perhaps accelerating comorbidities and frailty. In a workshop organized by the Association of Specialty Professors, the Infectious Diseases Society of America, the HIV Medical Association, the National Institute on Aging, and the National Institute on Allergy and Infectious Diseases, researchers in infectious diseases, geriatrics, immunology, and gerontology met to review what is known about HIV infection and aging, to identify research gaps, and to suggest high priority topics for future research. Answers to the questions posed are likely to help prioritize and balance strategies to slow the progression of HIV infection, to address comorbidities and drug toxicity, and to enhance understanding about both HIV infection and aging.

Entities:  

Mesh:

Year:  2008        PMID: 18627268      PMCID: PMC3130308          DOI: 10.1086/590150

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  166 in total

1.  Lack of decay of HIV-1 in gut-associated lymphoid tissue reservoirs in maximally suppressed individuals.

Authors:  Michael A Poles; W John Boscardin; Julie Elliott; Philip Taing; Marie M P Fuerst; Ian McGowan; Stephen Brown; Peter A Anton
Journal:  J Acquir Immune Defic Syndr       Date:  2006-09       Impact factor: 3.731

2.  The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study.

Authors:  Michael W Plankey; David G Ostrow; Ron Stall; Christopher Cox; Xiuhong Li; James A Peck; Lisa P Jacobson
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

3.  All-or-nothing treatment targets make bad performance measures.

Authors:  Rodney A Hayward
Journal:  Am J Manag Care       Date:  2007-03       Impact factor: 2.229

4.  Diversity of the Ig repertoire is maintained with age in spite of reduced germinal centre cells in human tonsil lymphoid tissue.

Authors:  G R Kolar; D Mehta; P C Wilson; J D Capra
Journal:  Scand J Immunol       Date:  2006-09       Impact factor: 3.487

5.  Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker.

Authors:  Huda Al-Mohri; Tanya Murphy; Ying Lu; Richard G Lalonde; Marina B Klein
Journal:  J Acquir Immune Defic Syndr       Date:  2007-04-01       Impact factor: 3.731

6.  TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection.

Authors:  Nicole L Yonkers; Benigno Rodriguez; Kimberly A Milkovich; Robert Asaad; Michael M Lederman; Peter S Heeger; Donald D Anthony
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

7.  Reduced aerobic capacity and physical functioning in older HIV-infected men.

Authors:  K K Oursler; J D Sorkin; B A Smith; L I Katzel
Journal:  AIDS Res Hum Retroviruses       Date:  2006-11       Impact factor: 2.205

8.  Long-term body composition and metabolic changes in antiretroviral naive persons randomized to protease inhibitor-, nonnucleoside reverse transcriptase inhibitor-, or protease inhibitor plus nonnucleoside reverse transcriptase inhibitor-based strategy.

Authors:  Judith C Shlay; Glenn Bartsch; Grace Peng; Jack Wang; Carl Grunfeld; Cynthia L Gibert; Fehmida Visnegarwala; Sai Subhasree Raghavan; Ying Xiang; Martha Farrough; Harold E Perry; Donald Kotler; Wafaa M El-Sadr
Journal:  J Acquir Immune Defic Syndr       Date:  2007-04-15       Impact factor: 3.731

9.  Relation of stavudine discontinuation to anthropometric changes among HIV-infected women.

Authors:  Phyllis C Tien; Michael F Schneider; Stephen R Cole; Jessica E Justman; Audrey L French; Mary Young; Jack DeHovitz; Niyati Nathwani; Todd T Brown
Journal:  J Acquir Immune Defic Syndr       Date:  2007-01-01       Impact factor: 3.731

10.  Hepatocellular carcinoma and non-Hodgkin's lymphoma: the roles of HIV, hepatitis C infection, and alcohol abuse.

Authors:  Kathleen A McGinnis; Shawn L Fultz; Melissa Skanderson; Joseph Conigliaro; Kendall Bryant; Amy C Justice
Journal:  J Clin Oncol       Date:  2006-11-01       Impact factor: 44.544

View more
  227 in total

1.  Age at cancer diagnosis among persons with AIDS in the United States.

Authors:  Meredith S Shiels; Ruth M Pfeiffer; Eric A Engels
Journal:  Ann Intern Med       Date:  2010-10-05       Impact factor: 25.391

2.  Effects of randomized rosuvastatin compared with placebo on bone and body composition among HIV-infected adults.

Authors:  Kristine M Erlandson; Ying Jiang; Sara M Debanne; Grace A McComsey
Journal:  AIDS       Date:  2015-01-14       Impact factor: 4.177

Review 3.  What do we know about older adults and HIV? A review of social and behavioral literature.

Authors:  Andrea Sankar; Andrea Nevedal; Stewart Neufeld; Rico Berry; Mark Luborsky
Journal:  AIDS Care       Date:  2011-06-14

4.  Action on social determinants of health is essential to tackle noncommunicable diseases.

Authors:  Kumanan Rasanathan; Rüdiger Krech
Journal:  Bull World Health Organ       Date:  2011-10-01       Impact factor: 9.408

5.  Independent effects of HIV, aging, and HAART on brain volumetric measures.

Authors:  Beau M Ances; Mario Ortega; Florin Vaida; Jodi Heaps; Robert Paul
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-15       Impact factor: 3.731

6.  Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons.

Authors:  David J Moore; Miguel Arce; Suzanne Moseley; J Allen McCutchan; Jennifer Marquie-Beck; Donald R Franklin; Florin Vaida; Cristian L Achim; Justin McArthur; Susan Morgello; David M Simpson; Benjamin B Gelman; Ann C Collier; Christina M Marra; David B Clifford; Robert K Heaton; Igor Grant
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2011       Impact factor: 2.198

7.  HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group.

Authors:  Kevin P High; Mark Brennan-Ing; David B Clifford; Mardge H Cohen; Judith Currier; Steven G Deeks; Sherry Deren; Rita B Effros; Kelly Gebo; Jörg J Goronzy; Amy C Justice; Alan Landay; Jules Levin; Paolo G Miotti; Robert J Munk; Heidi Nass; Charles R Rinaldo; Michael G Shlipak; Russell Tracy; Victor Valcour; David E Vance; Jeremy D Walston; Paul Volberding
Journal:  J Acquir Immune Defic Syndr       Date:  2012-07-01       Impact factor: 3.731

8.  Effect of statin therapy in reducing the risk of serious non-AIDS-defining events and nonaccidental death.

Authors:  E T Overton; D Kitch; C A Benson; P W Hunt; J H Stein; M Smurzynski; H J Ribaudo; P Tebas
Journal:  Clin Infect Dis       Date:  2013-02-05       Impact factor: 9.079

9.  Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection.

Authors:  Sulggi A Lee; Elizabeth Sinclair; Vivek Jain; Yong Huang; Lorrie Epling; Mark Van Natta; Curtis L Meinert; Jeffrey N Martin; Joseph M McCune; Steven G Deeks; Michael M Lederman; Frederick M Hecht; Peter W Hunt
Journal:  J Infect Dis       Date:  2014-02-28       Impact factor: 5.226

10.  Growing older with HIV/AIDS: new public health challenges.

Authors:  Sean Cahill; Robert Valadéz
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.